Defining Hyperprogressive Disease During Immunotherapy for Non–Small Cell Lung Cancer
This multicenter cohort study assess the accuracy of each definition of hyperprogressive disease to identify the frequency and associations with poorer outcomes of immune-checkpoint inhibitor therapy in patients with advanced non–small cell lung cancer and offers an optimized and homogenized…